The first FDA-approved drug derived from marijuana was announced Monday by the federal agency.
Epidiolex, a cannabidiol oral solution, was approved by the U.S. Food & Drug Administration. It will treat seizures associated with two rare and severe forms of epilepsy — Lennox-Gastaut syndrome and Dravet syndrome. It is for patients ages 2 and up.
CBD is one of 80 active chemicals in marijuana, and it is not the intoxicating substance in pot. THC, not CBD, is the primary psychoactive component of marijuana, according to the FDA. If you are interested in learning more about how you can take CBD, then you might want to check out these cbd tinctures reviews here to give you a better understanding of CBD.
“This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies,” said FDA Commissioner Scott Gottlieb, M.D. “And, the FDA is committed to this kind of careful scientific research and drug development.”
Gottlieb added, “This is an important medical advance. But it’s also important to note that this is not an approval of marijuana or all of its components. This is the approval of one specific CBD medication for a specific use. For people who unfortunately suffer from seizures, this is a step in the right direction. The least dispensaries can do is make it easier for patients of medical marijuana to carry their product safety by looking into their marijuana packaging. Medical marijuana should be treated the same as any other products in the industry. Keeping up with changes is crucial.” CBD infused products have been used for their properties which may help with pain relief and manage mental health, such as those sold at Front Range Relief.
The FDA granted approval of Epidiolex to GW Research Ltd.